AHNS Presidential Award: Novel Therapeutic Targets and Combinations in Head and Neck Cancer Grant

The AHNS Presidential Award supports innovative research targeting novel therapeutic approaches in head and neck cancer. With a funding amount of $15,000 for one year, this grant encourages projects that utilize advanced methodologies such as genomics and immune profiling. Applicants must be AHNS members in good standing and provide letters of support from their institution. The goal is to foster research that can lead to significant advancements in treatment strategies for this challenging disease.

AHNS Presidential Award: Novel Therapeutic Targets and Combinations in Head and Neck Cancer
$15,000, one year. One available.
Purpose
The purpose of this award is to support research projects that seek to identify novel therapeutic targets and combinations in head and neck cancer. Proposed studies may utilize genomics, immune profiling, mechanistic approaches, human tissues (preferred) and/or animal models to identify novel therapeutic targets in the tumor or microenvironment, based on biological dependencies.
Conditions
Research supported by this award should be specifically directed to identify novel therapeutic targets and rational combinations in head and neck cancer with a translational focus. Projects that demonstrate collaborative effort with members of other related disciplines are encouraged. Projects must be designed so as to yield useful information within the period of award, but priority will be given to projects that are also innovative with promise to develop into new long-range or expanded research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s academic department and from the principal scientific advisor or mentor. These letters are to indicate a general level of support of the applicant, the fact that the Department will make time, space, and other resources accessible for completion of the project, and that the applicant will have appropriate supervision/support throughout the period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the project.
Use of Funds
A detailed budget and budget justification constitute part of the application and will be
evaluated as part of the review process.  Allowable expenses include consultant fees (e.g., statistician); salary support for research assistants or other technical personnel; computer software or hardware; purchase and maintenance of experimental animals; laboratory supplies and services; and expenses related to publication of results directly related to the supported project, exclusive of reprint costs. Equipment and supplies purchased with this Award become the property of the recipient institution. The AHNS prefers not to pay institutional (indirect) costs for this very modest award; if the institution is unwilling to waive such costs, however, they are limited to no more than 10% of the Total Direct Costs (sum of amounts requested for personnel, consultant costs, equipment, supplies, patient/animal care costs, and other expenses). The Total Costs (direct + indirect) may not exceed $10,000.

Eligibility

Candidates for this award should reside in the U.S. or Canada, be medical students, residents, PhDs or faculty members at the rank of associate professor or below and be an AHNS member in good standing. Previous AHNS or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant.Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from AHNS must choose only one of the awards.The grant is legally awarded to the institution with which the Principal Investigator is affiliated, not to the investigator or his/her Division or Department.
You must be a member of this organization to apply for this award - become a member. Must be AHNS members in good standing

Ineligibility

Funding may not be used to support the Principal Investigator’s salary during the period of the award.